97 related articles for article (PubMed ID: 11798160)
1. Activation mechanism of solubilized epidermal growth factor receptor tyrosine kinase.
Ge G; Wu J; Wang Y; Lin Q
Biochem Biophys Res Commun; 2002 Jan; 290(3):914-20. PubMed ID: 11798160
[TBL] [Abstract][Full Text] [Related]
2. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
Li J; Ma C; Huang Y; Luo J; Huang C
Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890
[TBL] [Abstract][Full Text] [Related]
3. Activation of epidermal growth factor receptor by epidermal growth factor.
Sherrill JM; Kyte J
Biochemistry; 1996 May; 35(18):5705-18. PubMed ID: 8639530
[TBL] [Abstract][Full Text] [Related]
4. Kinase-deficient neu proteins suppress epidermal growth factor receptor function and abolish cell transformation.
Qian X; Dougall WC; Hellman ME; Greene MI
Oncogene; 1994 May; 9(5):1507-14. PubMed ID: 7908733
[TBL] [Abstract][Full Text] [Related]
5. Identification of EGF receptor C-terminal sequences 1005-1017 and di-leucine motif 1010LL1011 as essential in EGF receptor endocytosis.
Wang Q; Zhu F; Wang Z
Exp Cell Res; 2007 Sep; 313(15):3349-63. PubMed ID: 17643422
[TBL] [Abstract][Full Text] [Related]
6. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations.
Bremm A; Walch A; Fuchs M; Mages J; Duyster J; Keller G; Hermannstädter C; Becker KF; Rauser S; Langer R; von Weyhern CH; Höfler H; Luber B
Cancer Res; 2008 Feb; 68(3):707-14. PubMed ID: 18245470
[TBL] [Abstract][Full Text] [Related]
7. Ligand-induced protein tyrosine kinase activity in living cells coexpressing intact EGF receptors and receptors with an extensive cytosolic deletion.
Dou Y; Hoffman P; Hoffman BL; Carlin C
J Cell Physiol; 1992 Nov; 153(2):402-7. PubMed ID: 1429858
[TBL] [Abstract][Full Text] [Related]
8. The actin binding domain of the epidermal growth factor receptor is required for EGF-stimulated tissue invasion.
van der Heyden MA; Van Bergen en Henegouwen PM; de Ruiter N; Verdaasdonk MA; van den Tweel JG; Rijksen G; Boonstra J; Joling P
Exp Cell Res; 1997 Aug; 234(2):521-6. PubMed ID: 9260923
[TBL] [Abstract][Full Text] [Related]
9. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor.
Zhang X; Gureasko J; Shen K; Cole PA; Kuriyan J
Cell; 2006 Jun; 125(6):1137-49. PubMed ID: 16777603
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor (EGFR) signaling in cancer.
Normanno N; De Luca A; Bianco C; Strizzi L; Mancino M; Maiello MR; Carotenuto A; De Feo G; Caponigro F; Salomon DS
Gene; 2006 Jan; 366(1):2-16. PubMed ID: 16377102
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of mitogenic pathways through kinase-impaired mutants of the epidermal growth factor receptor.
Ewald JA; Coker KJ; Price JO; Staros JV; Guyer CA
Exp Cell Res; 2001 Aug; 268(2):262-73. PubMed ID: 11478852
[TBL] [Abstract][Full Text] [Related]
12. A basic peptide within the juxtamembrane region is required for EGF receptor dimerization.
Aifa S; Aydin J; Nordvall G; Lundström I; Svensson SP; Hermanson O
Exp Cell Res; 2005 Jan; 302(1):108-14. PubMed ID: 15541730
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of activation of the tyrosine kinase of a deletion mutant of epidermal growth factor receptor missing the sites of self-phosphorylation.
Sherrill JM; Kyte J
Biochemistry; 1999 Mar; 38(10):3106-11. PubMed ID: 10074364
[TBL] [Abstract][Full Text] [Related]
14. S-Nitrosylation of the epidermal growth factor receptor: a regulatory mechanism of receptor tyrosine kinase activity.
Murillo-Carretero M; Torroglosa A; Castro C; Villalobo A; Estrada C
Free Radic Biol Med; 2009 Feb; 46(4):471-9. PubMed ID: 19056486
[TBL] [Abstract][Full Text] [Related]
15. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
Johnson FM; Saigal B; Donato NJ
J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
[TBL] [Abstract][Full Text] [Related]
16. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
Zhang T; Ma J; Cao X
Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
[TBL] [Abstract][Full Text] [Related]
17. Regeneration of human epidermis on acellular dermis is impeded by small-molecule inhibitors of EGF receptor tyrosine kinase.
Forsberg S; Ostman A; Rollman O
Arch Dermatol Res; 2008 Oct; 300(9):505-16. PubMed ID: 18446355
[TBL] [Abstract][Full Text] [Related]
18. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
[TBL] [Abstract][Full Text] [Related]
19. Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells.
Perez-Torres M; Valle BL; Maihle NJ; Negron-Vega L; Nieves-Alicea R; Cora EM
Exp Cell Res; 2008 Oct; 314(16):2907-18. PubMed ID: 18687326
[TBL] [Abstract][Full Text] [Related]
20. Thermodynamic mixing of molecular states of the epidermal growth factor receptor modulates macroscopic ligand binding affinity.
Holbrook MR; Slakey LL; Gross DJ
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):99-108. PubMed ID: 11062062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]